Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, ORIC Pharmaceuticals Inc’s stock clocked out at $12.19, down -2.32% from its previous closing price of $12.48. In other words, the price has decreased by -$2.32 from its previous closing price. On the day, 0.71 million shares were traded. ORIC stock price reached its highest trading level at $12.48 during the session, while it also had its lowest trading level at $12.02.
Ratios:
To gain a deeper understanding of ORIC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.13 and its Current Ratio is at 16.13. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 08, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $15.
On October 31, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $20.Wells Fargo initiated its Overweight rating on October 31, 2024, with a $20 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 06 ’25 when Piscitelli Dominic sold 11,000 shares for $14.52 per share. The transaction valued at 159,719 led to the insider holds 48,317 shares of the business.
Chacko Jacob sold 37,461 shares of ORIC for $461,520 on Oct 06 ’25. The PRESIDENT AND CEO now owns 531,419 shares after completing the transaction at $12.32 per share. On Oct 06 ’25, another insider, Dominic Piscitelli, who serves as the Officer of the company, bought 50,000 shares for $14.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 1183929088 and an Enterprise Value of 937666880.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.31, which has changed by 0.46823525 over the last 52 weeks, in comparison to a change of 0.1476624 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.93, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is 0.18%, while the 200-Day Moving Average is calculated to be 31.53%.
Shares Statistics:
It appears that ORIC traded 1.25M shares on average per day over the past three months and 1069480 shares per day over the past ten days. A total of 86.19M shares are outstanding, with a floating share count of 55.10M. Insiders hold about 43.27% of the company’s shares, while institutions hold 67.29% stake in the company. Shares short for ORIC as of 1761868800 were 15494904 with a Short Ratio of 12.44, compared to 1759190400 on 11242529. Therefore, it implies a Short% of Shares Outstanding of 15494904 and a Short% of Float of 16.16.
Earnings Estimates
. The current rating of ORIC Pharmaceuticals Inc (ORIC) reflects the combined expertise of 11.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.22 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$1.29 and -$2.53 for the fiscal current year, implying an average EPS of -$1.71. EPS for the following year is -$1.71, with 11.0 analysts recommending between -$1.03 and -$2.84.
